The Bill & Melinda Gates Medical Research Institute obtains license for continued development of M72/AS01E tuberculosis vaccine candidate from GSK
Sign up for The Optimist newsletter
Subscribe to The Optimist to get weekly updates on the latest in global health, gender equality, education, and more.